<?xml version="1.0" encoding="UTF-8"?>
<document id="30272645">
	<sentence id="s1" text="Familial hypercholesterolemia (FH) is mostly caused by low-density lipoprotein receptor (LDLR) mutations and results in an increased risk of early-onset cardiovascular disease due to marked elevation of LDL cholesterol (LDL-C) in blood.">
		<entity id="s1.e1" charOffset="9-29"
			type="HP" text="hypercholesterolemia" ontology_id="HP_0003124"/>
		<entity id="s1.e2" charOffset="89-93"
			type="GENE" text="LDLR" ontology_id="3949"/>
		<entity id="s1.e3" charOffset="153-175"
			type="HP" text="cardiovascular disease" ontology_id="HP_0001626"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="true"/>
		<pair id="s1.p2" e1="s1.e2"
		    e2="s1.e3" pgr="true"/>
	</sentence>
	<sentence id="s2" text="Statins are the first line of lipid-lowering drugs for treating FH and other types of hypercholesterolemia, but new approaches are emerging, in particular PCSK9 antibodies, which are now being tested in clinical trials.">
		<entity id="s2.e1" charOffset="86-106"
			type="HP" text="hypercholesterolemia" ontology_id="HP_0003124"/>
		<entity id="s2.e2" charOffset="155-160"
			type="GENE" text="PCSK9" ontology_id="255738"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="true"/>
	</sentence>
</document>
